Donepezil Transdermal Patch Approved for Alzheimer Disease
Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion.
Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion.
Foods rich in calcium and protein like milk, yogurt, and cheese slow bone loss and improve insulin-like growth factor 1, which promotes bone and tissue growth. Researchers studied whether adding these to the diets of people aged 80 and older at care facilities would decrease their risk of hip fractures and falls.
The approval was based on data from the phase 3 GEMINI 1 and GEMINI 2 studies that evaluated Vuity in a total of 750 patients aged 40 to 55 years with presbyopia.
The study authors utilized the National Social Life, Health, and Aging Project leave-behind questionnaire to obtain data on a total of 6017 adults over 65 years of age.
DA01 is an investigational pluripotent stem cell-derived dopaminergic neuron therapy designed to replace the midbrian dopaminergic neurons lost in Parkinson disease.
Prior to the COVID-19 pandemic, that more than 60% of US adults were lonely; these numbers only increased during the pandemic. Clinicians should focus more time on the psychological and social factors of aging to improve the quality of life of the elderly.
Donanemab is an investigational antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.
Lecanemab (BAN2401) is an investigational anti-amyloid beta protofibril antibody
for the treatment of Alzheimer disease.
Using the FOS, the FOS Offspring, and CHAMP studies, researchers studied the relationship between dietary fiber and risk for hip fracture in older men.